A Boston biotech investment firm led by Bihua Chen that invests in private and public life sciences companies and is a frequent name in crossover rounds. Its website could not be reached at the time of research.
Cormorant Asset Management is a Boston-based life sciences investor that, according to the task hint, participates in private financings and public offerings of biotechnology companies, including oncology developers. At the time of research the domain cormorantcapital.com redirected to a GoDaddy 'for sale' parking page, an alternative (cormorantasset.com) did not resolve, and no Wikipedia article exists, so the firm's own description, founding year and portfolio could not be confirmed from a primary source.
Shares 858 Therapeutics, Third Arc Bio, Tango Therapeutics and the tag vc.
Shares MOMA Therapeutics, Synnovation Therapeutics, Terremoto Biosciences and the tag vc.
Shares Stablix, 858 Therapeutics and the tag vc.
Shares Antares Therapeutics, Third Arc Bio and the tag vc.
Shares Antares Therapeutics, Third Arc Bio and the tag vc.
Shares MOMA Therapeutics, Tango Therapeutics and the tag vc.
Shares Third Arc Bio, Tango Therapeutics and the tag vc.
Shares BlossomHill Therapeutics, Terremoto Biosciences and the tag vc.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/